Cite Filings / ALDX / 0001167557-26-000229

Feed Companies Filings Check

Sign in

SCHEDULE 13G/A

Statement of Beneficial Ownership

Aldeyra Therapeutics, Inc. Filed 2026-11-12 Acc 0001167557-26-000229

Documents 1

SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

2026-11-12 SCHEDULE 13G/A Statement of Beneficial Ownership
2026-11-09 8-K Other events
2026-11-06 SCHEDULE 13G Statement of Beneficial Ownership
2026-11-05 10-Q Quarterly Report
2026-07-27 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…